NFT
MIRM icon

Nan Fung Trinity’s Mirum Pharmaceuticals MIRM Stock Holding History

Nan Fung Trinity’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2M Hold
232,679
– – 2.69% 15
2026
Q1 		$21.5M Buy
232,679
+5,200
+2% +$489K 2.36% 14
2025
Q4 		$18M Buy
227,479
+71,214
+46% +$5.11M 1.42% 25
2025
Q3 		$11.5M Buy
156,265
+9,500
+6% +$604K 1.14% 36
2025
Q2 		$7.47M Buy
+146,765
New +$6.53M 0.89% 38

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nan Fung Trinity's MIRM Position: Q2 2026 in Review

Nan Fung Trinity held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 232,679 shares worth $27.2M. The position accounts for 2.69% of the portfolio, ranked #15.

Nan Fung Trinity first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Nan Fung Trinity held 232,679 shares of Mirum Pharmaceuticals worth $27.2M as of Q2 2026.
  • Nan Fung Trinity left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up 2.69% of Nan Fung Trinity's portfolio in Q2 2026, its #15 holding.
  • Nan Fung Trinity first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Nan Fung Trinity's 13F filing for Q2 2026, filed 24 Jul 2026.